Mymd Pharmaceuticals Stock Total Debt
MYMDDelisted Stock | USD 1.82 0.02 1.09% |
MyMD Pharmaceuticals fundamentals help investors to digest information that contributes to MyMD Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of MyMD Stock. The fundamental analysis module provides a way to measure MyMD Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MyMD Pharmaceuticals stock.
MyMD |
MyMD Pharmaceuticals Company Total Debt Analysis
MyMD Pharmaceuticals' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current MyMD Pharmaceuticals Total Debt | 48.87 K |
Most of MyMD Pharmaceuticals' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MyMD Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, MyMD Pharmaceuticals has a Total Debt of 48.87 K. This is 100.0% lower than that of the Biotechnology sector and 99.98% lower than that of the Health Care industry. The total debt for all United States stocks is 100.0% higher than that of the company.
MyMD Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MyMD Pharmaceuticals' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MyMD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MyMD Pharmaceuticals by comparing valuation metrics of similar companies.MyMD Pharmaceuticals is currently under evaluation in total debt category among its peers.
MyMD Fundamentals
Return On Equity | -1.01 | |||
Return On Asset | -0.5 | |||
Current Valuation | 2.99 M | |||
Shares Outstanding | 2.37 M | |||
Shares Owned By Insiders | 6.61 % | |||
Shares Owned By Institutions | 6.62 % | |||
Number Of Shares Shorted | 263.62 K | |||
Price To Book | 0.46 X | |||
EBITDA | (17.12 M) | |||
Net Income | (4 M) | |||
Cash And Equivalents | 5.62 M | |||
Cash Per Share | 0.15 X | |||
Total Debt | 48.87 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 2.41 X | |||
Book Value Per Share | 4.54 X | |||
Cash Flow From Operations | (12.98 M) | |||
Short Ratio | 2.71 X | |||
Earnings Per Share | (9.27) X | |||
Beta | 2.69 | |||
Market Capitalization | 4.31 M | |||
Total Asset | 17.86 M | |||
Retained Earnings | (101.98 M) | |||
Working Capital | 828.25 K | |||
Net Asset | 17.86 M |
About MyMD Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MyMD Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MyMD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MyMD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in MyMD Stock
If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Directory Find actively traded commodities issued by global exchanges |